ASTRAZENECA PLC AZN

Andy Barnett — Head of Investor Relations

Pascal Soriot — Chief Executive Officer

Aradhana Sarin — Chief Financial Officer or Head of Finance

David Fredrickson — Executive/Head of Oncology or similar

Susan Galbraith — Executive/Head of Oncology R&D or similar

Ruud Dobber — Executive/Head of Biopharmaceuticals or similar

Menelas Pangalos — Executive/Head of Mid- to Late-Stage Pipeline CVRM or similar

Marc Dunoyer — Executive/Head of Rare Disease or similar

+4.8%1d on move date+5.6% vs SPY3d+8.3%5d+8.3%

Research tier

Behavioral profile computed for 8 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more AZN calls or request research access.

More AZN calls Browse calls Request research access